GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Scientists at the Huntington Medical Research Institutes have developed a method for reproducibly generating tissue-engineered, 3-D tumor models that contain both tumor cells and stromal elements with a microscopic architecture. The team says the models are so tissue-like that they call them tumor histoids.

Each histoid is a few tenths of a millimeter in diameter. They are formed by spontaneous interaction of two or more cell types during histoid culture without a support matrix. They also can be produced in quantities large enough for moderately high-throughput drug screening, according to the researchers.

During this week’s podcast team member Dr. Marylou Ingram discusses in detail the process and tissue-engineering techniques the scientists used to create the novel tumor models. She also describes what makes these particular models so unique. In addition, Dr. Ingram goes over the range of potential applications for their tissue-engineered tumor models.

Add a comment

Add a comment

Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

GEN Poll

Secure Science

Should bans on science education, of the sort imposed on Iranians hoping to study physics and engineering in the United States, encompass other nationals and other fields of study, including biotechnology?

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

56.6%

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.